Mc Carthy Asset Management, Inc. Alkermes Plc. Transaction History

Mc Carthy Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$26.4 - $30.54 $2,376 - $2,748	-90 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$21.47 - $32.08 $1,932 - $2,887	90 New	90 $2,000
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $2,103 - $2,891	-90 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$18.78 - $25.15 $1,690 - $2,263	90 New	90 $2,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.